X

Other Industries

Meet the newest weed stock with $19 mil in revenues – Sundial Growers

Almost a year ago, cannabis firm Tilray (NASDAQ: TLRY) went public to much fanfare. Within just around 50 days of…

Earnings: Celsion Q2 loss narrows on lower expenses

Image for representation only. Photo courtesy: Chokniti Khongchum (Pexels) Oncology drug development company Celsion Corporation (NASDAQ: CLSN) Thursday reported a…

Bio-Path’s loss expands in Q2

Biotech company Bio-Path Holdings (NASDAQ: BPTH) reported a loss of $2.5 million or $0.87 per share for the second quarter…

Canadian Solar’s Q2 results beat market estimates

Canadian Solar Inc. (NASDAQ: CSIQ) beat market expectations for revenue and earnings in the second quarter of 2019. Analysts had…

Canopy Growth stock falls on wider-than-expected Q1 loss; revenue surges

Canopy Growth (NYSE: CGC) Wednesday said its first-quarter revenues more than tripled, aided by solid harvest. However, the cannabis firm…

Agilent Technologies stock surges on Q3 earnings beat, lifts fiscal outlook

Agilent Technologies (NYSE: A) stock surged above 7% after the bell as the company raised its full-year headline numbers. Third…

Arcadia Biosciences swings to profit in Q2

Arcadia Biosciences (NASDAQ: RKDA) swung to profit in the second quarter from a loss last year, helped by the change…

Neptune Wellness Solutions loss widens in Q1; CFO Mario Paradis steps down

Neptune Wellness Solutions' (NASDAQ: NEPT) net loss increased to C$6.5 million for the first quarter 2020 ended June 30, 2019,…

Bio-Path likely to report wider Q2 loss on Aug. 15

Bio-Path Holdings (NASDAQ: BPTH) is expected to continue incurring significant operating losses in the second quarter. Also, the losses are…

CorMedix narrows loss in Q2, revenue miss estimates

CorMedix (NYSE: CRMD) reported mixed second quarter results after the bell. Revenue failed to beat estimates, while earnings came in…